Evidence map›Paper›PMID 28912605›Full record

ArticleScientific reports2017

Peripheral human CD4

Marie-Laure Clénet, François Gagnon, Ana Carmena Moratalla, Emilie C Viel, Nathalie Arbour

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Double Positive CD4Frontiers in immunology · 2019
    Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Functionally heterogeneous intratumoral CD4Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. A review of CD4Veterinary immunology and immunopathology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marie-Laure ClénetDepartment of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC, H2X 0A9, Canada.
François GagnonDepartment of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC, H2X 0A9, Canada.
Ana Carmena MoratallaDepartment of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC, H2X 0A9, Canada.
Emilie C VielDepartment of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC, H2X 0A9, Canada.
Nathalie ArbourDepartment of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC, H2X 0A9, Canada. nathalie.arbour@umontreal.ca.
Université de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD4

Indexed as

Immunologic MemoryBiomarkersCD4 AntigensCD8 AntigensCells, CulturedCytokinesCytotoxicity, ImmunologicHumansImmunophenotypingInterleukin-15Interleukin-2Interleukin-7PhenotypeT-Lymphocyte SubsetsBiomarkersCD4 AntigensCD8 AntigensCytokinesInterleukin-15Interleukin-2Interleukin-7

Identifiers

PMID28912605
PMCPMC5599513
OpenAlexW2755361936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.